In an era of highly effective treatment, hepatitis C screening of the United States general population should be considered.
Liver Int
; 38(2): 258-265, 2018 02.
Article
in En
| MEDLINE
| ID: mdl-28719013
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Antiviral Agents
/
Mass Screening
/
Hepatitis C, Chronic
Type of study:
Diagnostic_studies
/
Etiology_studies
/
Prognostic_studies
/
Risk_factors_studies
/
Screening_studies
Aspects:
Patient_preference
Limits:
Humans
Country/Region as subject:
America do norte
Language:
En
Journal:
Liver Int
Journal subject:
GASTROENTEROLOGIA
Year:
2018
Document type:
Article
Affiliation country:
United States
Country of publication:
United States